Aktivolabs, a digital health science company, has announced its HIPAA compliance and the launch of its operations in the United States. The company’s mission is to globally prevent chronic diseases through its real-time digital health platform, which empowers enterprises and governments to develop scalable, evidence-based health and well-being solutions.
Aktivolabs secured a $10 million capital injection for a Series A round in December 2022, led by Mitsui & Co., Ltd., Adaptive Capital Partners, and SEEDS Capital, the investment arm of Enterprise Singapore. With its launch in the U.S., Aktivolabs plans to expand its team, engage with new clients and partners, and continue innovating in the field of digital health science and data.
HIPAA compliance is a significant milestone for Aktivolabs, demonstrating the company’s commitment to maintaining the highest standards of data security and privacy. Aktivolabs already boasts over half a million paid subscribers, with global clients and partners that include well-known names such as Marsh Mercer, AXA, Sunlife, and Dai-ichi.
The U.S. healthcare market represents a vast opportunity for digital health companies, given that more than 65% of it is privately driven. This opens doors for Aktivolabs to collaborate directly with insurers, employers, and government entities.
Gourab Mukherjee, Co-founder and CEO of Aktivolabs, emphasized the importance of HIPAA compliance as a symbol of the company’s dedication to data security and privacy. Hemant Kumar, Chief Operating Officer of Aktivolabs, highlighted that compliance not only meets regulatory requirements but also signifies data privacy excellence.
Gourab Mukherjee further noted that the U.S. healthcare system’s substantial spending presents both challenges and opportunities, making Aktivolabs’ expansion and HIPAA certification critical steps in becoming a trusted partner in the U.S. market.
Aktivolabs has demonstrated its commitment to data security and privacy with certifications such as ISO 27001, ISO 27701, ISO 13485, and compliance with privacy regulations like GDPR, PDPA, and DPA. These measures ensure the highest standards in data protection and privacy.
Aktivolabs’ current product portfolio includes the Aktivo Score®, Aktivo® Mind and Glucolife®.
Aktivolabs offers a range of innovative digital health solutions designed to empower individuals in their pursuit of better physical and mental well-being. These solutions include:
- Aktivo Score®: Developed by a team of elite doctors and data scientists, Aktivo Score® serves as a comprehensive guide to maintaining a healthy physical lifestyle for long-term health. It quantifies the combined impact of daily physical activities and sleep on an individual’s long-term health. This score provides a meaningful indicator of the overall healthiness of one’s physical lifestyle.
- Aktivo® Mind: Aktivo® Mind is a personalized digital guide tailored to enhance mental well-being and resilience. It leverages cognitive behavioral techniques (CBT) exercises to help individuals improve their mental health, reduce stress, and enhance overall well-being.
- Glucolife®: Glucolife® is a self-care and management guide designed to assist individuals in managing pre-diabetes and type-2 diabetes. It empowers users to take control of their lives and proactively address the global rise in prediabetes and diabetes by providing valuable self-care resources and guidance.
Gourab Mukherjee, CEO of Aktivolabs, emphasizes the company’s commitment to helping the U.S. population better understand and reduce the risk of chronic diseases.
Through the utilization of real-time digital health data, Aktivolabs aims to enable healthier and happier lives across different cultures and regions. The company’s focus on innovation and data-driven solutions positions it as a valuable partner in the pursuit of long-term health and well-being.
Founded in 2017 by a dedicated team of medical doctors and data scientists, Aktivolabs is on a global mission to combat chronic diseases. The company’s real-time digital health platform serves as a catalyst, empowering enterprises and governments to create scalable, evidence-based health and well-being solutions.
Aktivolabs boasts a diverse client portfolio, including some of the world’s largest insurance companies, health super-apps, major employers, consumer products companies, and enterprise-level corporations.
Aktivolabs has garnered significant support from prominent investors, including Mitsui & Co., SEEDS Capital (the investment arm of Enterprise Singapore), and Adaptive Capital Partners. This support enables Aktivolabs to drive innovation and expand its reach in the pursuit of healthier populations worldwide.
Headquartered in Singapore, Aktivolabs has established a global presence with offices in New York, Cambridge, and India. With its multidisciplinary team and cutting-edge solutions, Aktivolabs is at the forefront of leveraging digital health data to tackle chronic diseases and promote well-being on a global scale.